Acid Phosphatase Diag. Kit
by Sclavo, Inc. 510(k)
Active
510(k) K781489
Overview
The Acid Phosphatase Diagnostic Kit is a device intended to measure the activity of the acid phosphatase enzyme in plasma and serum. It is classified as a Clinical Chemistry device and is used for diagnostic purposes.
This kit is supplied by Sclavo, Inc. and is a Class II device with FDA 510(k) clearance. It is regulated under product code CJN and received FDA clearance on October 3, 1978. The device is intended for laboratory use and measures acid phosphatase activity in clinical specimens.
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK781489 | Date3 Oct 1978 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not known
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 6 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- CJN
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.1020
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent
Other devices from Sclavo, Inc.
Questions
What is the Acid Phosphatase Diagnostic Kit used for?
The Acid Phosphatase Diagnostic Kit is used to measure the activity of the acid phosphatase enzyme in plasma and serum specimens for diagnostic purposes in clinical laboratory settings.
How is the Acid Phosphatase Diagnostic Kit supplied?
The kit is supplied by Sclavo, Inc. as a Class II device intended for laboratory use. It contains all necessary components for measuring acid phosphatase activity in clinical specimens.
Is the Acid Phosphatase Diagnostic Kit single-use or reusable?
The device is intended for laboratory use and measures acid phosphatase activity in clinical specimens. The description does not specify whether individual components are single-use or reusable.
What is the regulatory status of the Acid Phosphatase Diagnostic Kit?
The Acid Phosphatase Diagnostic Kit is a Class II device with FDA 510(k) clearance (K781489) received on October 3, 1978. It is regulated under product code CJN and is classified as a Clinical Chemistry device.